Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

NCT04789408 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due to futility

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: KITE-222

Sponsor

Kite, A Gilead Company